# Collegium Pharmaceutical, Inc: Form 8-K, filed Jun 2, 2021

- Company: [Collegium Pharmaceutical, Inc](/companies/coll.md) (CIK 1267565)
- Form: 8-K
- Filed: 2021-06-02
- Accepted by EDGAR: Jun 2, 2021, 16:02 ET
- Period: 2021-06-02
- Accession: 0001104659-21-075715
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1267565/000110465921075715/tm2118117d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1267565/000110465921075715/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1267565/000110465921075715/tm2118117d1_8k.htm

Filed Jun 2, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-075715. Last ingested by Listed: Nov 5, 2026, 12:06 ET. No prices; not investment advice.